Orphanin FQ/Nociceptin receptor binding studies

Peptides

Volumn 21, Issue 7, 2000, Pages 949-960

  Dooley, Colette T ^a   Houghten, Richard A ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; GLASS FIBER; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE PEPTIDE; PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; BINDING COMPETITION; BINDING KINETICS; BINDING SITE; BRAIN; CELL LINE; HEART; ISOTOPE LABELING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; REVIEW;

EID: 0033821749     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00231-X     Document Type: Article

References (65)

1. Adapa I.D., Toll L. Neuropeptides. Neuropeptides. 31:1997;403-408.
2. Albrecht E, Samovilova NN, Oswald S, Baeger I, Berger H. J Pharmacol Exp Ther 1998;286:896-902.
3. Ardati A, Henningsen RA, Higelin J, Reinscheid RK, Civelli O, Monsma FJ Jr. Mol Pharmacol 1997;51:816-24.
4. Bauer U, Nakazi M, Kathmann M, Göthert M, Schlicker E. Naunyn-Schmiedeberg's Arch Pharmacol 1999;359:17-20.
5. Becker JAJ, Wallace A, Garzon A, et al. J Biol Chem 1999;274:27513-22.
6. Benyhe S, Monory K, Farkas J. Biochem Biophys Res Commun 1999;260:592-6.
7. Berger H, Albrecht E, Wallukat G, Bienert M. Br J Pharmacol 1999;126:555-8.
8. Bigoni R, Giuliani S, Calo' G, et al. Naunyn-Schmiedeberg's Arch Pharmacol 1999;359:160-7.
9. Bunzow JR, Saez C, Mortrud M, et al. FEBS Lett 1994;347:284-8.
10. Butour J-L, Moisand C, Mazarguil H, Mollereau C, Meunier C. Eur. J. Pharmacol. 1997;321:97-103.
11. Butour J-L, Moisand C, Mollereau C, Meunier J-C. Eur J Pharmacol 1998;349:R5-R6.
12. Calò G, Rizzi A, Bodin M, et al. Can J Physiol Pharmacol 1997;75:713-8.
13. Champion HC, Pierce RL, Kadowitz PJ. Regul Pept 1998;78:69-74.
14. Chen Y, Fan Y, Liu J, et al. FEBS Lett 1994;347:279-83.
15. Cheng ZJ, Fan GH, Zhao J, et al. Neuroreport 1997;8:1913-8.
16. Connor M, Vaughan CW, Chieng B, Christie M. Br J Pharmacol 1996;119:1614-8.
17. Dooley CT, Houghten RA. Life Sciences 1996;59:PL23-PL29.
18. Dooley CT, Spaeth CG, Craymer K, et al. J Pharmacol Exp Ther 1997;283:735-41.
19. Dumont M, Lemaire S. J Mol Cell Cardiol 1998;30:2751-60.
20. Dunnill RJ, Kakizawa K, McKnight AT. Br J Pharmacol 1996;119:275P.
21. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH. Science 1992;258:1952-5.
22. Fawzi AB, Zhang H, Weig B, Hawes B, Graziano MP. Eur J Pharmacol 1997;336:233-42.
23. Foddi MC, Mennini T. Neurosci Lett 1997;230:105-8.
24. Fukuda K, Kato S, Mori K, et al. FEBS Lett. 1994;343:42-6.
25. Guerrini R, Calo' G, Bigoni R et al. Regul. Pept. 1999;80:124.
26. Guerrini R, Calo' G, Rizzi A, et al. J Med Chem 1997;40:1789-93.
27. Guerrini R, Calo' G, Rizzi A, et al. Br J Pharmacol 1998;123:163-5.
28. Hulme E.C., Birdsall N.J.M. In Hulme EC, editor . Receptor-ligand interactions a practical approach the practical approach series . 1992;63-176 Oxford University Press, New York.
29. Jia YP, Linden DR, Serie JR, Seybold VS. Neurosci Lett 1998;250:21-4.
30. Kapusta DR, Sezen SF, Chang JK, Lippton H, Kenigs VA. Life Sci 1996;60:PL15-PL21.
31. Kavaliers M, Choleris E, Saucier DM. Peptides 1997;18:943-7.
32. Kawamoto H, Ozaki S, Itoh Y, et al. J Med Chem 1999;42:5061-3.
33. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. Proc Natl Acad Sci USA 1992;89:12048-52.
34. Lachowicz JE, Shen Y, Monsma FJ Jr, Sibley DR. J Neurochem 1995;64:34-40.
35. Lapalu S, Moisand C, Mazarguil H, Cambois G, Mollereau C, Meunier JC. FEBS Lett 1997;417:333-6.
36. Ma L, Cheng ZJ, Fan GH, Cai YC, Jiang LZ, Pei G. FEBS Lett 1997;403:91-4.
37. Makman MH, Dvorkin B. Eur J Pharmacol 1997;338:171-6.
38. Makman MH, Lyman WD, Dvorkin B. Brain Res 1997;762:247-50.
39. Mathis JP, Ryan-Moro J, Chang A, Hom JSH, Scheinberg DA, Pasternak GW. Biochem Biophys Res Commun 1997;230:462-5.
40. Matthes H, Seward EP, Kieffer B, North RA. Mol Pharmacol 1996;50:447-50.
41. Meng F, Taylor LP, Hoversten MT, et al. J Biol Chem 1996;271:32016-20.
42. Meunier JC, Mollereau C, Toll L, et al. Nature 1995;377:532-5.
43. Mollereau C, Moisand C, Butour JL, Parmentier M, Meunier JC. FEBS Lett 1996;395:17-21.
44. Mollereau C, Mouledous L, Lapalu S, et al. Mol Pharmacol 1999;55:324-31.
45. Mollereau C, Parmentier M, Mailleux P, et al. FEBS Lett 1994;341:33-8.
46. Montiel JL, Cornille F, Roques BP, Noble F. J Neurochem 1997;68:354-61.
47. Nicholson JR, Paterson SJ, Menzies JRW, Corbett AD, McKnight AT. Can J Physiol Pharmacol 1998;76:304-13.
48. Noda Y, Mamiya T, Nabeshima T, Nishi M, Higashioka M, Takeshima H. J Biol Chem 1998;273:18047-51.
49. Nothacker HP, Reinscheid RK, Mansour A, et al. Proc Natl Acad Sci USA 1996;93:8677-82.
50. Okawa H, Hirst RA, Smart D, McKnight AT, Lambert DG. Neurosci Lett 1998;246:49-52.
51. Okawa H, Nicol B, Bigoni R, et al. Br J Pharmacol 1999;127:123-30.
52. Pan Y-X, Cheng J, Xu J, et al. Mol Pharmacol 1995;47:1180-8.
53. Pan Y-X, Xu J, Ryan-Moro J, Mathis J, Hom JSH, Mei J, Pasternak GW. FEBS Lett 1996;395:207-10.
54. Reinscheid RK, Ardati A, Monsma FJ, Civelli O. J Biol Chem 1996;271:14163-8.
55. Reinscheid RK, Higelin J, Henningsen RA, Monsma FJ Jr, Civelli O. J Biol Chem 1998;273:1490-5.
56. Reinscheid RK, Nothacker HP, Bourson A, et al. Science 1995;270:792-4.
57. Shimohigashi Y, Hatano R, Fujita T, et al. J Biol Chem 1996;271:23642-5.
58. Sim LJ, Xiao R, Childers SR. Neuroreport 1996;7:729-33.
59. Varani K, Calo' G, Rizzi A, et al. Br J Pharmacol 1998;125:1485-90.
60. Wang JB, Johnson PS, Imai Y, et al. FEBS Lett 1994;348:75-9.
61. Werthwein S, Bauer U, Nakazi M, Kathmann, M, Schlicker E. Br J Pharmacol 1999;127:300-8.
62. Wick MJ, Minnerath SR, Lin X, Elde R, Law P-Y, Loh HH. Mol Brain Res 1994;27:37-44.
63. Wnendt S, Krüger T, Janocha E, Hildebrandt D, Englberger W. Mol Pharmacol 1999;56:334-8.
64. Zhang G, Murray TF, Grandy DK. Brain Res 1997;772:102-6.
65. Zhang S, Yu LJ. J Biol Chem 1995;270:22772-6.